Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Watch the webcasts from our industry partners' Satellite Symposia.


Bristol Myers Squibb
Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2   

Watch session

  • Welcome and introductions
    Vincenzo Bronte
  • Spotlight on I-O: Chemokine signaling and its role in tumor development and I-O resistance
    Vincenzo Bronte
  • Caught in a NET: Reviewing IL-8, CXCR1, and CXCR2 signaling in tumor biology
    Ignacio Melero
  • Emerging data for targeting IL-8, CXCR1, and/or CXCR2 as potential treatment options in solid tumors
    Matteo Simonelli
  • Closing remarks and audience Q&A
    Vincenzo Bronte


The need to advance checkpoint blockade for cancer immunotherapy and the potential role of the CD226 Axis 

Watch session 

  • Why is there a need to build on current immune checkpoint therapies?
    Solange Peters
  • What is the CD226 Axis?
    Solange Peters
  • How does the CD226 Axis regulate antitumor responses?
    Luis Paz-Ares
  • How is the CD226 Axis being studied in clinical trials?
    David Planchard
  • Panel discussion / Q&A
    Solange Peters

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.